EUCTR2004-000349-40-IT进行中（未招募）不适用
Efficacy of Exenatide Compared with Insulin Glargine in Patients with Type 2 Diabetes Using Metformin or Sulfonylurea for Whom Insulin is the Next Appropriate Therapy
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- ELI LILLY
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- 未提供
研究者
相似试验
进行中（未招募）
不适用
The effect of exenatide compared to insulin glargine on cardiac function and metabolism in type 2 diabetic patients with congestive heart failure (NYHA II): a randomized-controlled trialEUCTR2008-005325-10-NLVU University Medical Center42
已完成
4 期
The effect of exenatide compared to insulin glargine on cardiac function and metabolism in type 2 diabetic patients with congestive heart failure: a randomized-controlled trialDiabetic cardiomyopathyNL-OMON35173Vrije Universiteit Medisch Centrum62
已完成
4 期
A Comparison of Exenatide and Insulin GlargineType 2 DiabetesNCT02325960The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School44
已完成
4 期
Exenatide Compared With Insulin Glargine to Change Liver Fat Content in Type 2 DiabetesDiabetes Mellitus, Type 2Non-alcoholic Fatty Liver DiseaseNCT02303730Fudan University76
已完成
4 期
Effects of Exenatide in Type 2 Diabetic Patients With Congestive Heart FailureType 2 Diabetes MellitusCongestive Heart FailureNCT00766857Amsterdam UMC, location VUmc27